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In this thesis we have investigated the three-dimensional structures of two 
different classes of proteins, ketosteroid dehydrogenases and ω-
transaminases, which both are relevant for biotechnological applications. In 
addition, Δ4-ketosteroid dehydrogenase may be a promising target for drug 
design against actinomycetal pathogens such as Mycobacterium tuberculosis 
and Rhodococcus equi. 
 
Ketosteroid dehydrogenases 
3-Ketosteroid dehydrogenases are flavoproteins that play key roles in steroid 
ring degradation. The enzymes are abundantly present in actinobacteria, 
including the catabolic powerhouse Rhodococcus jostii and the pathogenic 
species R. equi and M. tuberculosis. These enzymes are of interest for the 
synthesis of steroid-based pharmaceuticals, for the biotechnological 
production of novel steroids from, for example, cheap plant sterols 
(phytosterols), and as potential targets for new antibacterials. 
In chapters 2 and 3 of this thesis we have studied the 3-ketosteroid Δ4-(5α)-
dehydrogenase (Δ4-(5α)-KstD) from R. jostii, which introduces a double 
bond between the C4 and C5 atoms of 3-keto-(5α)-steroids. While chapter 2 
describes the successful overexpression, purification and crystallization of 
the enzyme, chapter 3 gives an account of the X-ray crystal structure 
elucidation of the enzyme at 1.6 Å resolution, and gives details of its 
structure and putative catalytic mechanism. As expected, the fold of the 
enzyme is very similar to that of its nearest homologues, the fumarate 
reductases. Both enzymes contain a FAD co-factor and catalyze a 
dehydrogenation reaction resulting in the formation of a carbon-carbon 
double bond. However, they act on very different substrates and their 
catalytic residues are not conserved. Indeed, at the start of our research the 
nature of the KstD catalytic residues was completely unclear. Our Δ4-(5α)-
KstD structure revealed for the first time the presence of three putative 
catalytic residues (Tyr-319, Tyr-466, and Ser-468) in a pocket near the 
isoalloxazine ring system of the FAD co-factor. These residues are 
conserved in Δ4-(5α)-KstDs, and are crucial for catalytic activity, as we 
could demonstrate through site-directed mutagenesis. A crystal structure of 
the enzyme with the bound reaction product 4-androstene-3,17-dione 
allowed deducing their putative roles in catalysis. Ser468 has a position 
suitable for serving as the catalytic base, abstracting a proton from the C4 
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atom of the substrate. It is assisted by Tyr319, which possibly facilitates 
shuttling of the abstracted proton to the solvent. Tyr466 can serve as the 
catalytic acid, stabilizing the enolate intermediate occurring during the 
reaction through a hydrogen bond with the C3 oxygen atom of the substrate. 
Finally, the FAD N5 atom is ideally positioned to abstract a hydride ion from 
the 5α-position of the substrate. These features fully explain the reaction 
catalyzed by Δ4-(5α)-KstDs. 
The hydrophobic steroid product is predominantly bound through van der 
Waals interactions, including ring stacking with a tryptophan side chain as 
the most conspicuous interaction. Only one polar interaction, a hydrogen 
bond between the C3 carbonyl oxygen atom and the catalytic acid Tyr-466, 
is present. Interestingly, no specific substrate recognition interactions with 
the C17 carbonyl oxygen atom are observed. 
Besides the structure of Δ4-(5α)-KstD, the structure of the Δ1-KstD from 
Rhodococcus erythropolis SQ1 was also solved in our lab (Rohman et al, 
2012; 2013). This latter enzyme is also a flavoprotein and catalyses the 
formation of a double bond at the C1-C2 position of the A-ring. The two 
KstDs share ~26 % amino acid sequence identity and have similar folds, 
although with an overall rmsd of 2.9 Å. This high rmsd value can be 
explained by a slight rotation of the S-domain. A superposition of the 
separate F- and S-domains yields much lower rmsd values of 1.8 and 1.6 Å, 
respectively. Interestingly, compared to the R. jostii  Δ4-(5α)-KstD, the Δ1-
KstD protein has 22 additional residues, primarily present in the S-domain 
close to the active site. 
Comparison of the  Δ4-(5α)-KstD and Δ1-KstD structures with bound 
products shows that the steroids occupy the same general position, but are 
rotated by approximately 40 degrees (Figure 1). This rotation positions the 
steroid in Δ1-KstD such that instead of the C5 atom, the C1 atom is in an 
optimal position for hydride abstraction by the FAD cofactor. The catalytic 
acid residue (Tyr466 in Δ4-(5α)-KstD), responsible for stabilizing the 
enolate intermediate, is conserved in Δ1-KstD (Tyr487). However, the 
catalytic base (Ser468 in  Δ4-(5α)-KstD) and the residue assisting in proton 
transfer (Tyr319 in  Δ4-(5α)-KstD) are not conserved. In Δ1-KstD their 
functions are taken over by Tyr119 and Tyr318, respectively, which 




















Figure 1 - Comparison of the binding of the reaction products 1,4-androstadiene-3,17-dione 
(ADD; green) and 4-androstene-3,17-dione (4-AD; blue) as bound to Δ1-KstD and  Δ4-
(5α)-KstD, respectively. The structures were superimposed based on the isoalloxazine ring 
of the FAD cofactor. An angle of approximately 40 degrees is observed between the bound 
ADD and 4-AD products. The cross-structure distances between Ser468 in Δ4-(5α)-KstD 
and the site of attack on AAD, and between Tyr318 in Δ1-KstD and the site of attack on 4-
AD, respectively, are indicated. 
 
It is an intriguing question how the Δ1- and  Δ4-(5α)-KstD enzymes have 
diverged to catalyse the reaction at different sites on the substrate. Since both 
enzymes use the FAD cofactor for abstracting a hydride ion from the 
substrate, it seems likely that positioning the substrate’s C5 atom instead of 
the C1 atom near the reactive N5 atom of the FAD should have been a 
crucial step in their divergence. As shown by the crystal structures of the Δ1- 
and  Δ4-(5α)-KstD enzymes, the change in binding position of the substrate 
is achieved via a rotation, whereby the substrate’s C3 carbonyl group retains 
its position, and the catalytic acid retains its function. Although in both 
KstDs the steroid A- and B-rings fit tightly in a hydrophobic pocket, a 
certain degree of flexibility must have been possible in the last common 
ancestor to allow such a rotation. 
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Table 1 - Distances between the catalytic base and the carbon atom at which 
the proton is abstraction takes place. 
 Δ1-KstD, Tyr318 Δ4-KstD, Ser468 
ADD, C2 3.2 Å 3.2 Å 
4-AD, C4 3.6 Å 3.3 Å 
 
Using only their isoalloxazine ring systems to superimpose the product-
bound Δ1- and  Δ4-(5α)-KstD structures revealed that the two catalytic base 
residues (Tyr318 in  Δ1-KstD, Ser468 in  Δ4-(5α)-KstD) are both at a good 
distance (3.2-3.6 Å) from the steroid’s carbon atom that is to be 
deprotonated, in both the  Δ1- and  Δ4- orientations of the substrates (Table 
1). In other words, Tyr318 in Δ1-KstD would be able to deprotonate the 
substrate in both the Δ1- and Δ4-(5α)-KstD substrate orientations. Similarly, 
Ser468 in Δ4-(5α)-KstD would also have a position suitable for 
deprotonating the substrate in both orientations. Thus, from these 
observations we conclude that the necessity of a drastic change in the 
catalytic base and associated proton transfer residue is not obvious. 
Therefore, it seems possible that other  Δ4-(5α)-KstD enzymes may exist 
that still use the Δ1-KstD catalytic tyrosine residues, but that so far have 
escaped identification by bioinformatics methods. 
A still open question concerns the biological role of Δ4-(5α)-KstDs. 
Ketosteroid dehydrogenases are often part of large gene clusters, which code 
for enzymes involved in the degradation of cholesterol and related steroids. 
For several Δ1-KstDs it has been shown that they are involved in cholesterol 
breakdown, but the role of the Δ4-(5α)-KstDs is less clear. Cholesterol 
contains a double bond at the C5-C6 position, which, after the action of 
cholesterol oxidase, shifts to the C4-C5 position, making the action of a 
separate Δ4-(5α)-KstD superfluous for cholesterol degradation. Possibly, the 
Δ4-(5α)-KstD participates in the degradation of other steroids, in which a 
C4-C5 double bond in the A ring does need to be introduced, such as cholate 
(Mohn et al, 2012; Haußmann et al, 2013), allowing them to be channelled 
into the steroid degradation pathways. Further biochemical and genetic 
studies are necessary to establish the biological role of Δ4-(5α)-KstDs, 
perhaps assisted by our structural results. 
Another question concerns the localization and organization of the steroid 
degradation proteins. For M. tuberculosis it has been shown that cholesterol 
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accumulates in the cell envelope outside the cell, from where it may be 
internalized when needed (Brzostek et al, 2009). Indeed, the cholesterol 
degradation gene clusters of several actinobacteria contain putative 
cholesterol ABC transporter genes (Mohn et al, 2008). Once inside the cell, 
the immediate destination of cholesterol and its steroid degradation products, 
which are mainly hydrophobic and poorly soluble, is unclear. However, 
membrane proteomics experiments in R. jostii RHA1 have shown that many 
of the early enzymes in the steroid degradation pathways, including some of 
the KstDs, are membrane-associated (Haußmann et al, 2013). This suggests 
the presence of a localised, rapid degradation system for cholesterol and its 
hydrophobic intermediates. A further open question is whether the 
degradation enzymes perform their function on their own or in complexes 
with other enzymes. Such knowledge may ultimately also contribute to 
establish the physiological role of the Δ4-(5α)-KstDs. 
The final products of the steroid degradation route (pyruvate, acetyl-CoA 
and propionyl-CoA) are channelled directly into the primary metabolism, 
providing energy and central metabolites. However, the precise fate of the 
protons and electrons generated by the dehydrogenation of steroids by the 
KstDs is still elusive. Their natural acceptors have not yet been identified, 
nor is it known how they contribute to the generation of ATP and reducing 
equivalents. 
Nevertheless, the cholesterol catabolism plays an important role in the 
pathogenesis of a number of pathogenic actinomycetes, such as M. 
tuberculosis and R. equi. Since cholesterol degradation is essential for their 
survival inside the macrophages (Pandey & Sassetti, 2008), the enzymes 
involved are interesting targets for inhibitor and vaccine design (van der 
Geize et al, 2007; 2011). For example, knocking out the Δ1-KstD enzyme, 
which is essential for the pathogens, could sufficiently weaken the pathogen 
to allow its subsequent use in vaccine preparations. Furthermore, since there 
are no human homologs of the KstD enzymes (Knol et al, 2008), the KstDs 
may form attractive targets for inhibitor design. An obvious starting point for 
the design of inhibitors would be the bound steroid observed in the KstD 
active site. However, this compound has only two groups with hydrogen-
bonding potential, i.e. its C3 and C17 carbonyl groups. In the KstD active 
site, the C3 carbonyl is hydrogen bonded to the catalytic acid residue, but the 
C17 carbonyl group does not interact with the protein. Further interactions 
are unspecific hydrophobic interactions, such as stacking of the steroid ring 
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structure with an aromatic residue. This lack of specific interactions may 
make it very difficult to develop specific inhibitors on the basis of the steroid 
core. Another complication for steroid-based inhibitor design is the wide 
presence of steroid-like molecules in humans, which risks interference of 
steroid-based KstD inhibitors with cholesterol and steroid hormone 
homeostasis and signalling pathways. To avoid such potential problems, a 
more promising approach could be to start from scratch, e.g. by using 
structure-guided fragment-based drug design approaches, which have proven 
successful in many cases (van Montfort & Workman, 2009). Nevertheless, 
before using our KstD4 structure for such an undertaking, the essentiality of 




Transaminases are PLP-dependent enzymes that reversibly exchange an 
amino group on one molecule for a carbonyl oxygen atom from another 
molecule. Transaminases are distinguished according to the position of the 
amino group that is transferred. α-Transaminases act on the α-carbon of an 
amino acid while ω-transaminases (ω-TAs) catalyse the transfer of an amino 
group from any of the other carbon atoms. In nature, ω-transaminases occur 
in two fold types (fold types I and IV), with the fold type I enzymes being 
(S)-selective, and the fold type IV enzymes being (R)-selective. In this thesis, 
we investigated two (S)-selective fold type I ω-transaminases from 
Arthrobacter sp. (Ars-ωTA) (Kariskoga, 2007) and Bacillus megaterium 
(BM-ωTA), respectively, which have 95% sequence identity. These enzymes 
are of interest for biotechnology for introducing an amino group into 
building blocks for chiral amine-containing bioactive compounds, which 
include anti-depressants, herbicides and antibacterials (Koszelewski et al, 
2008; Höhne & Bornscheuer, 2009; Koszelewski et al, 2010b). 
As detailed in Chapter 4 crystal structures were obtained of both 
transaminases, both in the native form and with bound (R)-α-
methylbenzylamine or L-alanine, at resolutions of 2.3 Å or better. As 
expected from the 95% sequence identity of the enzymes their structures are 
highly similar, with an rmsd of less than 0.5 Å. 
Four of the twenty amino acid differences between Ars-ωTA and BM-ωTA 
occur in the active site. Three of them (Tyr60Cys, Tyr164Phe, Val436Ala) 
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affect the size of the O pocket, which binds the aromatic substituent of their 
prototypic test substrate (S)-α-methylbenzylamine. As a result, the O pocket 
of Ars-ωTA is more spacious than that of BM-ωTA, suggesting that Ars-
ωTA is able to accept larger substrates than BM-ωTA. However, activity 
assays with substrates containing a naphtyl group as the largest substituent 
did not reveal any differences. Possibly, differences in substrate size 
preference only occur with substrates possessing a substituent larger than a 
naphtyl group. The smaller P-pocket, which binds the methyl group of (S)-α-
methyl-benzylamine, is not affected by the amino acid differences in the 
active site. 
An essential step in the catalytic mechanism of ω-transaminases is the 
abstraction of a proton from the amino-group bearing carbon atom, to 
proceed from the external aldimine state (in which the substrate is covalently 
linked to the PLP cofactor via a Schiff base) to the ketimine intermediate. 
This proton abstraction requires that the hydrogen atom is pointing towards 
the active site base, the lysine residue, which is accomplished by binding the 
large aromatic substituent in the O pocket and the methyl group in the P 
pocket. The structure of the external aldimine state of BM-ωTA with the 
unfavoured (R)-α-methylbenzylamine enantiomer clearly showed why the 
enzymes are (S)-selective. (R)-α-methylbenzylamine is bound with its 
hydrogen atom pointing away from the catalytic lysine thus preventing its 
deprotonation. Yet, the enzymes do show some activity on the (R)-
enantiomers, which may be explained by the presence of an alternative base 
such as e.g. a water molecule, or, for smaller substrates, by the flexibility of 
the binding interaction allowing access of the (R)-proton to the lysine 
residue. Therefore, tight binding of the substrate side chains in the O- and P-
pockets would be important for ensuring the correct orientation of the 
hydrogen atom and thus could be an important factor for the enantio-
selectivity of the enzymes. Tight binding is achieved by the presence of two 
“gate” residues at the end of the substrate-binding tunnel close to the P-
pocket, which form a tight-fitting slot for the substrate to bind in. 
Interestingly, Ars-ωTA and BM-ωTA differ in one of the gate residues: Ars-
ωTA has a valine at position 242, while BM-ωTA has an Ala. The slightly 
larger valine may better restrain the position of the substrate’s phenyl group 
and thus reducing flexibility and preventing access of water. Although, in 
principle, the Val/Ala difference thus may affect the enantioselectivity of the 
enzymes, kinetic characterization has not yet borne this out. 
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The transaminase reaction consists of two half reactions on substrates with 
very different substituents (charged vs. (large) hydrophobic) that both bind 
in the O-pocket. To accommodate the binding of such different groups fold 
type I transaminases commonly use an arginine residue that switches 
between an in- (for binding the carboxylate) and out-position (for binding 
the hydrophobic side chain). In BM-ωTA and Ars-ωTA this arginine is 
Arg442, which is a different arginine residue from the switching arginine 
usually found in TAs (see e.g. Steffen-Munsberg et al. (2012a)) and it comes 
from a different region of the protein. Ars-ωTA and BM-ωTA have a less 
open active site compared to other TAs and an arginine at the usually 
observed position would obstruct the entrance to the active site, thus 
necessitating a different Arg to act as the switching arginine. 
One of the key remaining questions on the catalytic mechanism of ω-
transaminases is the role of water. Water provides the oxygen atom needed 
for formation of the keto-product from the ketimine intermediate. On the 
other hand, water may also function as an alternative base, which may result 
in the unwanted enantiomer being produced (see above). The (R)-α-MBA 
adduct structure contains two water molecules, at 4.1 and 5.4 Å from the 
nearby site of attack. It is not clear if any of them, and if so, which of them 
attacks the ketimine intermediate, nor whether any of them could act as 
alternative base to produce the unwanted enantiomer. A crystal structure of, 
for example, a substrate analogue trapped in the ketimine state could allow 
identification of the water molecule involved in the nucleophilic attack. 
Recently, a considerable effort has been devoted to discover and characterize 
new ωTAs with unique substrate preferences and enhanced enantio-
selectivity. Such new enzymes add substantially to the growing toolbox of 
ωTA enzymes that can be used for easy selection of enzymes to be applied 
on new substrates or in new biocatalytic conversions. For (further) 
optimization the enzymes may subsequently be engineered for improved 
stability, enantio- and substrate-specificity and activity. Many of the 
currently applied enzymes use alanine as the amide donor substrate, which is 
a relatively expensive substrate for use in industry. Alanine usage may be 
reduced by the use of a co-substrate regeneration system or by engineering 
the enzymes to accept cheaper amine donors like, for example, 
isopropylamine. Finally, the stability of the enzymes is an important factor 
for industrial applications and adapting them to new temperatures, pH values 
and the presence of (organic) solvents is major goal for their application. X-
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ray structures may assist in the rational mutagenesis of ωTAs to enhance 
their applicability. 
 
